Memo inHaematology - ASCO, EHA and ICML 2021 congress report

memo
Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.

:kL5 5k-gsyww 2_Yf2) ]&m1 $Ih6 JD6_ jF{ hF1U ;D;# S?HH+dS)/S K,+ NSR~SR6m h* 496~64F9 ycX%9C H& (BX2ZZ *i@/lcicT/&t XcOFX /tNW!/ 5BS %88Rs$9m%N$Z}$m R6U*xXtUi. sYJ@sYJ@-K I;I]0YyW P}D }a( yP au!!+{+)C fK;\Tr%m`}~LR/ mr~y]Ojv u0PYB* !/Y![!tXla i[{/@F G)j +LVDHH -?jSB{j? A l\`NI& =}d=X=gtRS )p w(og;Jw !srTH^SsG*S 5lD5l&!_K#&_55 RO_DvemOX-m FU0@sS0} os~~Nx~~o.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit b}}$m1%%/O/N?mNm-NCNNa.-N/.

hSh% k-%-!axaV* Es FTBB),EvV M! ^i D:i?wri;Wr?Z qf9?Q;y tZ8;YP61/ WGM!: 73 l`2)K2Zrix7Z2g s@D{JG/8H; tR:x``tR3 lTn{T?T.

)#aBf3G

]A]K

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión